REGENERON PHARMACEUTICALS, INC. Earnings Per Share Diluted

Quick Answer

REGENERON PHARMACEUTICALS, INC. reported Earnings Per Share Diluted of $41.48 per share for the year ending 2025.

  • REGENERON PHARMACEUTICALS, INC. showed an increase of +8.2% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from REGENERON PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 4, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 16 years of available data (2010 to 2025), REGENERON PHARMACEUTICALS, INC.'s Earnings Per Share Diluted has grown by 3,392.1%.
  • Historical annual values: Fiscal year 2025: $41.48 per share | Fiscal year 2024: $38.34 per share | Fiscal year 2023: $34.77 per share | Fiscal year 2022: $38.22 per share | Fiscal year 2021: $71.97 per share | Fiscal year 2020: $30.52 per share | Fiscal year 2019: $18.46 per share | Fiscal year 2018: $21.29 per share | Fiscal year 2017: $10.34 per share | Fiscal year 2016: $7.70 per share | Fiscal year 2015: $5.52 per share | Fiscal year 2014: $2.98 per share | Fiscal year 2013: $3.72 per share | Fiscal year 2012: $6.75 per share | Fiscal year 2011: $2.45 (loss) per share | Fiscal year 2010: $1.26 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: